Empirical/Statistical Studies
The Complications of Controlling Agency Time Discretion: FDA Deadlines and Postmarket Drug Safety. American Journal of Political Science. 2012.
.
Drug Review Deadlines and Subsequent Safety Problems. New England Journal of Medicine . 2008;358 (13) :1354-61.
.
Early-Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review. Journal of Law Economics and Organization . 2010;26 (2).
.
Groups the Media Agency Waiting Costs and FDA Drug Approval. American Journal of Political Science. 2002;46 (2) :490-505.
.